Contract Manufacturing

Novartis announced today that it opened a new 10,000-square-foot radioligand therapy (RLT) manufacturing facility in California. The state-of-the-art site in Carlsbad marks the latest milestone in the company’s previously announced $23 billion investment in U.S. infrastructure over the next five years. Novartis says the Carlsbad facility opening allows it to seamlessly meet future demand for…

Samsung Biologics announced today that it completed the spinoff of its Samsung Bioepis unit to focus on leading as a pure-play CDMO. Following approval from its board, Samsung Biologics separated its investment and subsidiary management business to establish Samsung Epis Holdings. It finalized its Decision on Nov. 1 with plans to proceed with registration for…

Trelleborg has announced the grand opening of its expanded manufacturing facility and BioPharma Center of Excellence in Northborough, Massachusetts. The new facility for the Plymouth, Massachusetts-based company drives its strategy for growth in the biopharmaceutical industry. “Our expanded BioPharma Center of Excellence supports our goal of being the partner of choice for all leading biopharmaceutical…

AbbVie (NYSE:ABBV) announced that it began construction for a $70 million expansion of its bioresearch center (ABC) in Worcester, Massachusetts. The ABC in Worcester serves as a center of excellence for biologics R&D and manufacturing. AbbVie said its latest expansion comes as part of a plan to invest more than $10 billion in the U.S.…

Amgen (Nasdaq: AMGN) recently announced it will invest $650 million to expand its biologics manufacturing facility in Juncos, Puerto Rico, a move expected to create nearly 750 jobs across construction and advanced manufacturing. The expansion will increase drug production capacity and integrate advanced technologies into operations, part of the company’s strategy to bolster its U.S.…

Fujifilm Biotechnologies recently announced it opened a $3.2 billion commercial-scale cell culture manufacturing site in Holly Springs, N.C., with eight 20,000-liter bioreactors and plans to double capacity. The facility is one of the largest commercial cell culture sites in North America, the company said. Phase one spans drug substance and drug product manufacturing, with finished…

Cardinal Health (NYSE:CAH) today announced plans for a new flagship forward distribution center in Indianapolis. The new, state-of-the-art facility will further expand and modernize its national pharmaceutical distribution network. Dublin, Ohio-based Cardinal Health plans to include automation and the latest technology advancements in the new plant. It hopes to support the segment’s distribution of more…

Gilead Sciences (Nasdaq:GILD) announced that it broke ground on its new pharmaceutical development and manufacturing (PDM) technical development center (NTDC) in California. The facility, located at the company’s Foster City headquarters, comes as part of a $32 billion investment in U.S. innovation through 2030. Gilead expects the investment to generate more than $43 billion in…

Thermo Fisher Scientific (NYSE:TMO) announced that it completed its acquisition of a Sanofi facility in New Jersey. The company acquired Sanofi’s state-of-the-art sterile fill-finish and packaging site in Ridgefield, New Jersey. In July, the company announced its plans to acquire this site and continue producing a portfolio of Sanofi therapies there while opening the facility…

Optel Group announced that it acquired Vanguard Robotics, an expert in end-of-line collaborative robot (cobot) automation. The acquisition reinforces Optel’s commitment to pharmaceutical automation as a leader in traceability and supply chain solutions. By integrating Vanguard’s robotics technology, Optel believes it can help pharmaceutical manufacturers address labor constraints. It also expects the deal to enhance…